Mitochondrial-derived peptide humanin alleviates AKI-to-CKD transition by inhibiting TRIM28-mediated ubiquitination of Suclg1.
Humanin may help protect against kidney fibrosis in the transition from AKI to CKD, but further research is needed to confirm its relevance in humans.
Where it sits
this study against the rest of the humanin corpusSummary and findings
This study investigated the role of humanin in the AKI-to-CKD transition using a murine model. Exogenous supplementation of S14G-humanin was found to protect against kidney fibrosis induced by ischemia-reperfusion injury. The study identified a mechanism involving the stabilization of Suclg1 through inhibition of TRIM28-mediated ubiquitination.
Abstract
Acute kidney injury (AKI) resulting from ischemia-reperfusion injury (IRI) may subsequently progress to chronic kidney disease (CKD) and eventually end-stage renal disease (ESRD). Humanin, a mitochondria-derived peptide, has been implicated in various physiological and pathological processes and exhibits cytoprotective effects against inflammation, apoptosis, and oxidative stress. Nevertheless, its role in the AKI-to-CKD transition remains poorly understood. This study showed that renal humanin expression was downregulated in a murine IRI model and this reduction was significantly correlated with renal function decline and kidney fibrosis progression. Exogenous supplementation of S14G-humanin (HN) was found to protect against kidney fibrosis induced by IRI. Mechanistically, HN attenuated kidney fibrosis by stabilizing succinate-CoA ligase subunit alpha (Suclg1) by inhibiting tripartite motif-containing protein 28 (TRIM28)-mediated ubiquitination of Suclg1. Inhibition of Suclg1 abolished the renoprotective effects of HN, underscoring the critical role of Suclg1 in the AKI-to-CKD transition. Moreover, HN-mediated upregulation of Suclg1 reduced superoxide dismutase 2 (SOD2) succinylation, linking metabolic reprogramming to mitochondrial dysfunction and fibrotic progression. Collectively, these findings reveal a critical role of humanin in mitigating kidney fibrosis and identify Suclg1 as a promising therapeutic target in the AKI-to-CKD transition.
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.